Member ID: password:
Directory and Search for Global Trade
more
Local Site: Global China Japan Korean Russia Vietnam France Spain India Germany Italian Argentina
Updated Day: Home > Offer to sell
High Quality USP Grade Ciprofloxacin (CAS: 85721-33-1) (C17H18FN3O3)
Category:Health & Medical/Animal & Veterinary/Veterinary Medicine
  • Post Date:2015-04-24 10:45:19
  • Expiry Date:6 months
  • Quantity:1000
  • Specs:Foil bags;Tin;Vails
  • Payment Method:Western Union;Bank transfer ;Money gram
Product Detail
Company Profile
Products List
Contact
High Quality USP Grade Ciprofloxacin (CAS: 85721-33-1) (C17H18FN3O3) Basic Info. Model NO.:85721-33-1 Product Name:Ciprofloxacin CAS:85721-33-1 Purity:95% Type:Antibiot IC and Antimicrobial Agents Export Markets:Global Additional Info. Trademark:yuancheng Packing:Foil Bag Standard:EP, USP Origin:China HS Code:8744665658 Production Capacity:541kg/Month Product Description High Quality High Puirity 99% (CAS: 85721-33-1) (C17H18FN3O3) Ciprofloxacin MF: C17H18FN3O3 CAS No.: 85721-33-1 Type: Antibiot IC and Antimicrobial Agents Purity: ≥ 93.0% Package: 25 kg / drum Quality Level: Meet USP33. Product Description Ciprofloxacin (INN) is an antibiotic useful for the treatment of a number of bacterial infections. It is a second-generation fluoroquinolone. Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections, including Gram-negative (Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Legionella pneumophila, Moraxella catarrhalis, Proteus mirabilis, and Pseudomonas aeruginosa), and Gram-positive (methicillin-sensitive, but not methicillin-resistant Staphylococcus aureus, Streptococcus pneumoniae, Staphylococcus epidermidis, Enterococcus faecalis, and Streptococcus pyogenes) bacterial pathogens. Medical uses Ciprofloxacin is used to treat a wide variety of infections, including infections of bones and joints, endocarditis, gastroenteritis, malignant otitis externa, respiratory tract infections, cellulitis, urinary tract infections, prostatitis, anthrax, and chancroid. Ciprofloxacin only treats bacterial infections; It does not treat viral infections such as the common cold. Although for certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent. Ciprofloxacin occupies an important role in treatment guidelines issued by major medical societies for the treatment of serious infections, especially those likely to be caused by Gram-negative bacteria, including Pseudomonas aeruginosa. For example, ciprofloxacin in combination with metronidazole is one of several first-line antibiotic regimens recommended by the Infectious Disease Society of America for the treatment of community-acquired abdominal infections in adults. It also features prominently in treatment guidelines for acute pyelonephritis, complicated or hospital-acquired urinary tract infection, acute or chronic prostatitis, certain types of endocarditis, certain skin infections, and prosthetic joint infections. In other cases, treatment guidelines are more restrictive, recommending in most cases that older, narrower-spectrum drugs be used as first-line therapy for less severe infections to minimize fluoroquinolone-resistance development. For example, the Infectious Disease Society of America recommends the use of ciprofloxacin and other fluoroquinolones in urinary tract infections be reserved to cases of proven or expected resistance to narrower-spectrum drugs such as nitrofurantoin or trimethoprim-sulfamethoxazole. The European Association for Urology recommends ciprofloxacin as an alternative regimen for the treatment of uncomplicated urinary tract infections, but cautions that the potential for "adverse events have to be considered". TESTING ITEM SPECIFICATION RESULT Characters Appearance White crystalline powder White crystalline powder Identification Meet the requirements Meet the requirements Tests Clarity of solution Meets the requirements Meets the requirements Loss on drying ≤ 1.0% Not more than 1.0% 0.2% Residue on ignition ≤ 0.1% Not more than 0.1% 0.1% Chloride ≤ 0.02% Not more than 0.02% < 0.02% Sulfate ≤ 0.04% Not more than 0.04% < 0.04% Heavy metals ≤ 0.002% Not more than 0.002% < 0.002% Fluoroquinolonic acid Meets the requirements Meets the requirements Impurities ≤ 0.5% Not more than 0.5% 0.21% Ciprofloxacin ethylenediamine analog ≤ 0.2% Not more than 0.2% 0.07% Any other individual impurity ≤ 0.2% Not more than 0.2% 0.06% Assay (on the dried basis) 98.0%~102.0% Between 98.0% and 102.0% 100%

The company invests large fund and brains to R&D department to research fine chemical, biochemical, pharmaceutical & its intermediates products that fit the demand of the market. High level research group, advanced apparatus and good scientific atmosphere ensure the quality of R&D. All the products in plant are the fruit of R&D department. Our products reach the advanced standard of domestic market, many of which reach the international standard.
    The company capital asserts is above 100 million RMB. According to the GMP standard, the company has built 10000 m2 plant equipped the advanced equipment. The factory has a complete Q.A. & Q.C. system. We own several sets of analyzing instruments with high efficiency and high sensitivity, such as HPLC, GC and UV spectrophotometer to analyze and control the products. The company has gotten the approval of ISO9001.We have the authority of export and import, Cinnamaldehyde, Cinnamic alcohol, Cinnamic acid, Vitamin E, Vitamin B1, produced by the company and other fine chemical, biochemical, pharmaceutical & its intermediates distributed by the company are sold both in the domestic and international market and highly recommended by our clients. In order to develop the market further, we are eager to cooperate with the manufactory and trading company around the globe to make a prosperous future.
At present, our main products are cinnamate series, anabolics series, L-carnitine, Melatonin, antipyrotic and antibacterial and so on. Our products reach the advanced standard of domestic market, many of which reach the international standard, pass Kocher certificate and ISO9001.

High Quality USP Grade Ciprofloxacin (CAS: 85721-33-1) (C17H18FN3O3) Basic Info. Model NO.:85721-33-1 Product Name:Ciprofloxacin CAS:85721-33-1 Purity:95% Type:Antibiot IC and Antimicrobial Agents Export Markets:Global Additional Info. Trademark:yuancheng Packing:Foil Bag Standard:EP, USP Origin:China HS Code:8744665658 Production Capacity:541kg/Month Product Description High Quality High Puirity 99% (CAS: 85721-33-1) (C17H18FN3O3) Ciprofloxacin MF: C17H18FN3O3 CAS No.: 85721-33-1 Type: Antibiot IC and Antimicrobial Agents Purity: ≥ 93.0% Package: 25 kg / drum Quality Level: Meet USP33. Product Description Ciprofloxacin (INN) is an antibiotic useful for the treatment of a number of bacterial infections. It is a second-generation fluoroquinolone. Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections, including Gram-negative (Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Legionella pneumophila, Moraxella catarrhalis, Proteus mirabilis, and Pseudomonas aeruginosa), and Gram-positive (methicillin-sensitive, but not methicillin-resistant Staphylococcus aureus, Streptococcus pneumoniae, Staphylococcus epidermidis, Enterococcus faecalis, and Streptococcus pyogenes) bacterial pathogens. Medical uses Ciprofloxacin is used to treat a wide variety of infections, including infections of bones and joints, endocarditis, gastroenteritis, malignant otitis externa, respiratory tract infections, cellulitis, urinary tract infections, prostatitis, anthrax, and chancroid. Ciprofloxacin only treats bacterial infections; It does not treat viral infections such as the common cold. Although for certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent. Ciprofloxacin occupies an important role in treatment guidelines issued by major medical societies for the treatment of serious infections, especially those likely to be caused by Gram-negative bacteria, including Pseudomonas aeruginosa. For example, ciprofloxacin in combination with metronidazole is one of several first-line antibiotic regimens recommended by the Infectious Disease Society of America for the treatment of community-acquired abdominal infections in adults. It also features prominently in treatment guidelines for acute pyelonephritis, complicated or hospital-acquired urinary tract infection, acute or chronic prostatitis, certain types of endocarditis, certain skin infections, and prosthetic joint infections. In other cases, treatment guidelines are more restrictive, recommending in most cases that older, narrower-spectrum drugs be used as first-line therapy for less severe infections to minimize fluoroquinolone-resistance development. For example, the Infectious Disease Society of America recommends the use of ciprofloxacin and other fluoroquinolones in urinary tract infections be reserved to cases of proven or expected resistance to narrower-spectrum drugs such as nitrofurantoin or trimethoprim-sulfamethoxazole. The European Association for Urology recommends ciprofloxacin as an alternative regimen for the treatment of uncomplicated urinary tract infections, but cautions that the potential for "adverse events have to be considered". TESTING ITEM SPECIFICATION RESULT Characters Appearance White crystalline powder White crystalline powder Identification Meet the requirements Meet the requirements Tests Clarity of solution Meets the requirements Meets the requirements Loss on drying ≤ 1.0% Not more than 1.0% 0.2% Residue on ignition ≤ 0.1% Not more than 0.1% 0.1% Chloride ≤ 0.02% Not more than 0.02% < 0.02% Sulfate ≤ 0.04% Not more than 0.04% < 0.04% Heavy metals ≤ 0.002% Not more than 0.002% < 0.002% Fluoroquinolonic acid Meets the requirements Meets the requirements Impurities ≤ 0.5% Not more than 0.5% 0.21% Ciprofloxacin ethylenediamine analog ≤ 0.2% Not more than 0.2% 0.07% Any other individual impurity ≤ 0.2% Not more than 0.2% 0.06% Assay (on the dried basis) 98.0%~102.0% Between 98.0% and 102.0% 100%
Betty-Yao
Contact Infomation
WUHAN YUANCHENG GONGCHUANG TECHNOLOGY CO.,LTD.
[China]
Contact:Betty-Yao
Address:
No.496,Zhongshan Road, Wuhan, Hubei, China
Tel:86-27-50756086
Fax:86-027-68886696-985
Http:www.made-in-china.com/
E-mail:ycgsales08@ycphar.com